FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Bijl

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Phagocytosis

Phenomena

Ultraviolet Rays

Co-author Network

Publications

TOP 3
C L Overman; Marc Bijl; André Hartkamp; J W J Bijlsma; Ercolie R Bossema; R H W M Derksen; G L R Godaert; Rinie Geenen
Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
A W S de Souza; Pieter C Limburg; Jantine L Westra; Marc Bijl; C G M Kallenberg
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
Nynke A Jager; Nato Teteloshvili; Johanna Westra; Clark J Zeebregts; Marc Bijl
Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Bijl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: C L Overman; Marc Bijl; André Hartkamp; J W J Bijlsma; Ercolie R Bossema; R H W M Derksen; G L R Godaert; Rinie Geenen
Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
Lupus 2012;21(14):1515-21.
2012: A W S de Souza; Pieter C Limburg; Jantine L Westra; Marc Bijl; C G M Kallenberg
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
Autoimmunity reviews 2012;11(12):909-17.
2012: Nynke A Jager; Nato Teteloshvili; Johanna Westra; Clark J Zeebregts; Marc Bijl
Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?
Autoimmunity reviews 2012;11(9):621-6.
2012: Suzanne Arends; Jo H M Berden; Stefan P Berger; Marc Bijl; Ruud G L de Sévaux; R H W M Derksen; Cecile Grootscholten; Alexandre E Voskuyl
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Annals of the rheumatic diseases 2012;71(6):966-73.
2012: Marc Bijl; J-M Dayer; M Gatto; E Israeli; N Agmon-Levin; Yehuda Shoenfeld
Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.
Autoimmunity reviews 2012;11(8):572-6.
2012: K M A C Luijten; J Tekstra; J W J Bijlsma; Marc Bijl
The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
Autoimmunity reviews 2012;11(5):326-9.
2011: M W Heijstek; I Koné-Paut; Kirsten Minden; L M Ott de Bruin; G Pileggi; A Ravelli; F van der Klis; M Abinun; Marc Bijl; R Borrow; M Borte; A Fasth; N M Wulffraat
Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations.
Autoimmunity reviews 2011;11(2):112-22.
2011: Sebastian Dolff; Minke G Huitema; Cees G M Kallenberg; Pieter C Limburg; Marc Bijl; Wayel Habib Abdulahad
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Clinical immunology (Orlando, Fla.) 2011;141(2):197-204.
2011: Sander Van Assen; Jantine L Westra; Aalzen De Haan; Katinka M Giezeman; Linda Gorter; Albert Holvast; Gerda Horst; Cees G M Kallenberg; Abraham M Palache; Denise S C Telgt; Marc Bijl
Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.
Clinical immunology (Orlando, Fla.) 2011;141(2):161-8.
2011: Helmy J Hinkema; Hans L A Nienhuis; Marc Bijl; Lodewijk de Groot; Andries J Smit; Arie M Van Roon; Marcel D Posthumus
Is small artery elasticity decreased prior to intima-media thickening in patients with longstanding rheumatoid arthritis?
The Journal of rheumatology 2011;38(10):2133-40.
2011: M W Heijstek; I Koné-Paut; Kirsten Minden; L M Ott de Bruin; G S Pileggi; Angelo Ravelli; F van der Klis; Nico M Wulffraat; M Abinun; Marc Bijl; R Borrow; M Borte; A Fasth
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.
Annals of the rheumatic diseases 2011;70(10):1704-12.
2011: Sander Van Assen; O Elkayam; N Agmon-Levin; R Cervera; M F Doran; M Dougados; P Emery; P Geborek; John Ioannidis; D R W Jayne; C G M Kallenberg; U Müller-Ladner; Y Shoenfeld; L Stojanovich; G Valesini; N M Wulffraat; Marc Bijl
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.
Autoimmunity reviews 2011;10(6):341-52.
2011: Jantine L Westra; Lodewijk de Groot; Shannon L Plaxton; Elisabeth Brouwer; Marcel D Posthumus; Cornelis G M Kallenberg; Marc Bijl
Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease.
Rheumatology (Oxford, England) 2011;50(4):665-73.
2011: Sander Van Assen; N Agmon-Levin; O Elkayam; R Cervera; M F Doran; M Dougados; P Emery; P Geborek; John Ioannidis; D R W Jayne; C G M Kallenberg; U Müller-Ladner; Y Shoenfeld; L Stojanovich; G Valesini; N M Wulffraat; Marc Bijl
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Annals of the rheumatic diseases 2011;70(3):414-22.
2011: Lodewijk de Groot; Helmy Hinkema; Cees G M Kallenberg; Andries J Smit; Jantine L Westra; Marc Bijl; Marcel D Posthumus
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
Arthritis research & therapy 2011;13(6):R205.
2011: Sebastian Dolff; Berber Doornbos-Van der Meer; Cees G M Kallenberg; Pieter C Limburg; Jantine L Westra; Wayel Habib Abdulahad; Marc Bijl
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.
Arthritis research & therapy 2011;13(5):R157.
2011: Deena A Abdulahad; Johan Bijzet; Cees G M Kallenberg; Pieter C Limburg; Jantine L Westra; Marc Bijl
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Arthritis research & therapy 2011;13(3):R71.
2010: Sebastian Dolff; Jo Hm Berden; Marc Bijl
Treatment of lupus nephritis.
Expert review of clinical immunology 2010;6(6):901-11.
2010: Henk A Martens; Sacha Gross; Gerrit van der Steege; Elisabeth Brouwer; Jo H M Berden; Ruud de Sevaux; R H W M Derksen; Alexandre E Voskuyl; Stefan P Berger; Gerjan J Navis; Cees G M Kallenberg; Marc Bijl
Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
The Journal of rheumatology 2010;37(11):2226-31.
2010: Sebastian Dolff; Wayel Habib Abdulahad; Marcory C R F van Dijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Urinary T cells in active lupus nephritis show an effector memory phenotype.
Annals of the rheumatic diseases 2010;69(11):2034-41.
2010: Lodewijk de Groot; Marcel D Posthumus; Cees G M Kallenberg; Marc Bijl
Risk factors and early detection of atherosclerosis in rheumatoid arthritis.
European journal of clinical investigation 2010;40(9):835-42.
2010: D A Abdulahad; Jantine L Westra; Pieter C Limburg; C G M Kallenberg; Marc Bijl
HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
Autoimmunity reviews 2010;9(10):661-5.
2010: Sander Van Assen; Albert Holvast; Denise S C Telgt; CA Benne; Aalzen De Haan; Jantine L Westra; Cees G M Kallenberg; Marc Bijl
Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.
Clinical immunology (Orlando, Fla.) 2010;136(2):228-35.
2010: André Hartkamp; Rinie Geenen; G L R Godaert; Marc Bijl; J W J Bijlsma; R H W M Derksen
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
Annals of the rheumatic diseases 2010;69(6):1144-7.
2010: Karina de Leeuw; Hans Nienhuis; Andries Smit; Coen A Stegeman; Cees Kallenberg; Marc Bijl
Increased accumulation of advanced glycation endproducts in patients with Wegener's granulomatosis.
Annals of the rheumatic diseases 2010;69(3):625-7.
2010: Hans L A Nienhuis; Karina de Leeuw; Johan Bijzet; Jasper J van Doormaal; Arie M Van Roon; Andries J Smit; Reindert Graaff; Cees G M Kallenberg; Marc Bijl
Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness.
Arthritis research & therapy 2010;12(5):R181.
2010: Karina de Leeuw; Johan Bijzet; Anne Marijn van der Graaf; Coen A Stegeman; Andries J Smit; Cees G Kallenberg; Marc Bijl
Patients with Wegener's granulomatosis: a long-term follow-up study.
Clinical and experimental rheumatology 2010;28(1 Suppl 57):18-23.
2010: Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.
Journal of cardiothoracic surgery 2010;5():13.
2010: Sander Van Assen; Albert Holvast; CA Benne; Marcel D Posthumus; Miek A van Leeuwen; Alexandre E Voskuyl; Marlies Blom; Anke P Risselada; Aalzen De Haan; Jantine L Westra; Cees G M Kallenberg; Marc Bijl
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
Arthritis and rheumatism 2010;62(1):75-81.
2009: Albert Holvast; Sander van Assen; Aalzen De Haan; Anke Huckriede; Cornelis A Benne; Jantine L Westra; Abraham Palache; Jan Wilschut; Cees G M Kallenberg; Marc Bijl
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Rheumatology (Oxford, England) 2009;48(10):1294-9.
2009: Anna L Bartels; Clark J Zeebregts; Marc Bijl; René A Tio; Riemer H J A Slart
Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries.
Annals of nuclear medicine 2009;23(8):753-6.
2009: S Dolff; W H Abdulahad; Marc Bijl; C G M Kallenberg
Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
Lupus 2009;18(7):575-80.
2009: A Holvast; Coen A Stegeman; C A Benne; A Huckriede; J C Wilschut; A M Palache; C G M Kallenberg; Marc Bijl
Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination.
Annals of the rheumatic diseases 2009;68(6):873-8.
2009: Hans L A Nienhuis; Johanna Westra; Andries J Smit; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.
Autoimmunity 2009;42(4):302-4.
2009: Henk A Martens; C G M Kallenberg; Marc Bijl
Role of CCR5 Delta32 bp deletion in RA and SLE.
Autoimmunity 2009;42(4):260-2.
2009: N Hu; J Westra; Minke G Huitema; Marc Bijl; Elisabeth Brouwer; Coen A Stegeman; Peter Heeringa; Pieter C Limburg; C G M Kallenberg
Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Arthritis and rheumatism 2009;60(5):1548-57.
2009: Henk A Martens; M W Zuurman; A H M de Lange; I M Nolte; G van der Steege; G J Navis; C G M Kallenberg; M A Seelen; Marc Bijl
Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Annals of the rheumatic diseases 2009;68(5):715-20.
2009: Henk A Martens; I M Nolte; G van der Steege; M Schipper; C G M Kallenberg; Gerard te Meerman; Marc Bijl
An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus.
Scandinavian journal of rheumatology 2009;38(4):256-62.
2008: Karina de Leeuw; Judith Blaauw; Aj Smit; Cg Kallenberg; Marc Bijl
Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired.
Lupus 2008;17(11):1010-7.
2008: H L Nienhuis; Karina de Leeuw; Johan Bijzet; A Smit; C G Schalkwijk; Reindert Graaff; Cees G M Kallenberg; Marc Bijl
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Rheumatology (Oxford, England) 2008;47(10):1554-8.
2008: Cees Gm Kallenberg; Marc Bijl
Why rheumatologists should be involved in the treatment of lupus nephritis.
Nature clinical practice. Nephrology 2008;4(2):60-1.
2008: Esther Reefman; H Kuiper; Pieter C Limburg; C G M Kallenberg; Marc Bijl
Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
Annals of the rheumatic diseases 2008;67(1):11-18.
2007: Esther Reefman; Gerda Horst; Marije T Nijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Arthritis and rheumatism 2007;56(10):3399-411.
2007: Karina de Leeuw; R Graaff; R de Vries; R P Dullaart; Andries J Smit; Cees G M Kallenberg; Marc Bijl
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2007;46(10):1551-6.
2007: André P van Rossum; Minke G Huitema; Coen A Stegeman; Marc Bijl; Karina de Leeuw; Miek A van Leeuwen; Pieter C Limburg; Cees G M Kallenberg
Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.
Annals of the rheumatic diseases 2007;66(10):1350-5.
2007: Hans L A Nienhuis; Karina de Leeuw; Andries J Smit; Johan Bijzet; Coen A Stegeman; Cees G M Kallenberg; Marc Bijl
Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis.
The Journal of rheumatology 2007;34(9):1875-81.
2007: Marc Bijl; Esther Reefman; Pieter C Limburg; Cees G M Kallenberg
Inflammatory clearance of apoptotic cells after UVB challenge.
Autoimmunity 2007;40(4):244-8.
2007: Bert Holvast; Anke Huckriede; Cees G M Kallenberg; Marc Bijl
Influenza vaccination in systemic lupus erythematosus: safe and protective?
Autoimmunity reviews 2007;6(5):300-5.
2007: Henk A Martens; Ilja M Nolte; Gerrit van der Steege; Martijn Schipper; Cees G M Kallenberg; Gerard te Meerman; Marc Bijl
Association of poly(ADP-ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus.
Annals of the rheumatic diseases 2007;66(3):424-5.
2007: Henk A Martens; Marc Bijl
Clinical images: blue-purple ears.
Arthritis and rheumatism 2007;56(2):673.
2007: Jan-Renier Moonen; Karina de Leeuw; Xavier J Gallego Y van Seijen; Cees G M Kallenberg; Marja J A van Luyn; Marc Bijl; Martin C Harmsen
Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus.
Arthritis research & therapy 2007;9(4):R84.
2007: Henk A Martens; Marc Bijl; Cees G M Kallenberg
Prognostic value of renal hemodynamic characteristics in patients with proliferative lupus nephritis.
Kidney & blood pressure research 2007;30(3):175-81.
2006: Esther Reefman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Do apoptotic cells accumulate in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation? Comment on the article by Kuhn et al.
Arthritis and rheumatism 2006;54(10):3373-4.
2006: A Holvast; Anke Huckriede; Jan Wilschut; Gerda Horst; J J C De Vries; C A Benne; Cees G M Kallenberg; Marc Bijl
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
Annals of the rheumatic diseases 2006;65(7):913-8.
2006: Esther Reefman; Hilde Kuiper; Marcel F Jonkman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.
Rheumatology (Oxford, England) 2006;45(5):538-44.
2006: Marc Bijl; Cees G M Kallenberg
Ultraviolet light and cutaneous lupus.
Lupus 2006;15(11):724-7.
2006: Karina de Leeuw; B Freire; Andries J Smit; Hendrika Bootsma; Cees G M Kallenberg; Marc Bijl
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus.
Lupus 2006;15(10):675-82.
2006: Esther Reefman; Marcelus C J M de Jong; Hilde Kuiper; Marcel F Jonkman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
Arthritis research & therapy 2006;8(6):R156.
2006: Cees G M Kallenberg; Coen A Stegeman; Hendrika Bootsma; Marc Bijl; Pieter C Limburg
Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?
Lupus 2006;15(7):397-402.
2006: Marc Bijl; Esther Reefman; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
Annals of the rheumatic diseases 2006;65(1):57-63.
2005: Karina de Leeuw; Cees G M Kallenberg; Marc Bijl
Accelerated atherosclerosis in patients with systemic autoimmune diseases.
Annals of the New York Academy of Sciences 2005;1051():362-71.
2005: Esther Reefman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy.
Annals of the New York Academy of Sciences 2005;1051():52-63.
2005: M E Grevink; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.
Journal of autoimmunity 2005;24(4):329-36.
2005: Marjolijn N Lub-de Hooge; E G E de Vries; Steven de Jong; Marc Bijl
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2005;64(6):854-8.
2005: Karina de Leeuw; Jan-Stephan F Sanders; Coen A Stegeman; A Smit; Cees G M Kallenberg; Marc Bijl
Accelerated atherosclerosis in patients with Wegener's granulomatosis.
Annals of the rheumatic diseases 2005;64(5):753-9.
2004: André Hartkamp; Rinie Geenen; G L R Godaert; Marc Bijl; J W J Bijlsma; R H W M Derksen
The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
Arthritis and rheumatism 2004;50(11):3591-5.
2004: André Hartkamp; Rinie Geenen; Marc Bijl; Aike A Kruize; G L R Godaert; R H W M Derksen
Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome.
Annals of the rheumatic diseases 2004;63(10):1335-7.
2004: Marc Bijl; Hendrika Bootsma; Ymke M van der Geld; Pieter C Limburg; Cees G M Kallenberg; Martin H van Rijswijk
Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Annals of the rheumatic diseases 2004;63(7):831-5.
2004: Jan-Leendert Brouwer; Marc Bijl; Nic J G M Veeger; Hanneke C Kluin-Nelemans; Jan van der Meer
The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.
Blood 2004;104(1):143-8.
2004: Karina de Leeuw; Marc Bijl; P L Jager
Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides.
Clinical and experimental rheumatology 2004;22(6 Suppl 36):S21-6.
2003: Esther Reefman; Hilde M Dijstelbloem; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.
Immunology and cell biology 2003;81(5):382-9.
2003: Marc Bijl; Gerda Horst; Hendrika Bootsma; Pieter C Limburg; Cees G M Kallenberg
Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.
Annals of the rheumatic diseases 2003;62(6):534-9.
2003: Marc Bijl; Gerda Horst; Johan Bijzet; Hendrika Bootsma; Pieter C Limburg; Cees G M Kallenberg
Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.
Arthritis and rheumatism 2003;48(1):248-54.
2002: Maarten M Boomsma; Marc Bijl; Coen A Stegeman; Cees G M Kallenberg; Gary S Hoffman; J W Cohen Tervaert
Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis.
Arthritis and rheumatism 2002;47(2):196-201.
2002: Marc Bijl; Hilde M Dijstelbloem; WW Oost; Hendrika Bootsma; R H W M Derksen; J Aten; Pieter C Limburg; Cees G M Kallenberg
IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2002;41(1):62-7.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes.
European journal of clinical investigation 2001;31(6):550-3.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2001;60(5):523-6.
2001: Peter Heeringa; Marc Bijl; A de Jager-Krikken; André Zandvoort; Gerard Dijkstra; Han Moshage; J W Cohen Tervaert; Anton T M G Tiebosch; Cees G M Kallenberg; Harry van Goor
Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis.
The Journal of pathology 2001;193(2):224-32.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity.
Lupus 2001;10(12):866-72.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).
Clinical and experimental immunology 2001;123(1):127-32.
2000: Hilde M Dijstelbloem; Marc Bijl; R Fijnheer; RH Scheepers; WW Oost; Marc D Jansen; Wim J Sluiter; Pieter C Limburg; R H W M Derksen; Jan G J van de Winkel; Cees G M Kallenberg
Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.
Arthritis and rheumatism 2000;43(12):2793-800.
2000: Marc Bijl; J Brouwer; G G Kallenberg
Cardiac abnormalities in SLE: pancarditis.
Lupus 2000;9(4):236-40.
1999: Marc Bijl; Miek A van Leeuwen; Martin H van Rijswijk
Transient osteoporosis of the hip: presentation of (a)typical cases and a review of the literature.
Clinical and experimental rheumatology 1999;17(5):601-4.
1999: T van Lopik; Marc Bijl; Margreet Hart; LC Boeije; T Gesner; A A Creasy; Cees G M Kallenberg; Lucien A Aarden; R J T Smeenk
Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse.
The Journal of rheumatology 1999;26(1):60-7.
1998: Marc Bijl; T van Lopik; Pieter C Limburg; P E Spronk; S M Jaegers; L A Aarden; R J T Smeenk; G G Kallenberg
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Journal of autoimmunity 1998;11(5):457-63.
1998: HR Koene; Marion Kleijer; A J Swaak; K E Sullivan; Marc Bijl; Michelle Petri; Cees G M Kallenberg; Dirk Roos; Albert E G Kr von dem Borne; Masja de Haas
The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus.
Arthritis and rheumatism 1998;41(10):1813-8.